Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are pleased to announce that Prof Joel Tarning has been awarded the biennial Grahame-Smith Prize by the British Pharmacological Society for outstanding contributions to clinical pharmacology. Joel has headed MORU's Clinical Pharmacology Department since 2012. Since then, the Department has grown into large, productive group that conducts laboratory- and computer-based pharmacology research.

Profesor Joel Tarning in a laboratory. © 2020 MORU. Photographer: Gerhard Jørén

Prof David Grahame-Smith, after whom the award Joel was honoured with is named, was Professor of Pharmacology at Oxford for several decades,” said Prof Nick Day, MORU Director. “He taught me as a medical student, and both Nick White and I both worked for him as junior doctors. He was a wonderful man, very funny and deeply humane in his clinical practice. It is very fitting that Joel has won an award associated with such a giant in the field.”

Joel's research interests include infectious disease pharmacology and the use of novel pharmacometric methodologies to identify and optimise the dose in particularly vulnerable populations, such as children and pregnant women. His work on the pharmacokinetic and pharmacodynamic properties of antimalarial drugs in young children with uncomplicated and severe malaria has already had a global impact, resulting in revised WHO Guidelines for the treatment of malaria. 

"David Grahame-Smith was a wonderful man," said Prof Sir Nick White. "Nick Day and I both worked for him. He was cheerful, positive, amusing and down to earth as well as being a world leading clinical pharmacologist and a very good physician. He was also an excellent jazz pianist. It is really nice for Joel to have deservedly won this award and, in doing so, to revive his memory."

As part of his award, Joel has been invited to give a prize lecture at a future, physical meeting of the Society. Please join us in extending your congratulations to Joel.

- Text by John Bleho

Similar stories

Arjen Dondorp, Peter Horby and Rose McGready elected Academy of Medical Sciences Fellows

Awards & Appointments MORU Bangkok SMRU

"Although it is hard to look beyond the pandemic right now," says President of the Academy of Medical Sciences Professor Dame Anne Johnson, "I want to stress how important it is that the Academy Fellowship represents the widest diversity of biomedical and health sciences. The greatest health advances rely on the findings of many types of research, and on multidisciplinary teams and cross-sector and global collaboration."

Pint of Science Thailand is back

MORU Bangkok Public Engagement

Live and on-line from Bangkok! Be ready for Thursday 13th May, when Pint of Science Thailand will stream live from Bangkok. Join us via Facebook, YouTube or right here from the Pint of Science Thailand website as we journey from bacterial infections to viruses, discover how clinical trials work, and how scientific development is seen in the eyes of the law!

Innovative strategies for engaging communities with malaria research

MORU Bangkok Public Engagement

For World Malaria Day 2021, F1000 Research Blog spoke to Professor Phaik Yeong Cheah about her research focussed on drama and arts-based community engagement for malaria research, published with Wellcome Open Research.

New project’s child-appropriate primaquine doses could have significant impact on global burden of malaria

MORU Bangkok

On Sunday 25 April, World Malaria Day, the Developing Paediatric Primaquine (DPP) project will launch its website. DPP will produce children-appropriate primaquine doses that could both cut malaria deaths in vulnerable African children by blocking transmission of P. falciparum malaria and reduce P. vivax malaria more widely.

Researchers call for access to Ivermectin for young children

MORU Bangkok Publication Research

Millions of children weighing less than 15kg are currently denied access to Ivermectin treatment due to insufficient safety data being available to support a change to the current label indication. The WorldWide Antimalarial Resistance Network’s new meta-analysis provides evidence that supports removing this barrier and improving treatment equity.

New report highlights growing concern of vaccine falsification

MORU Bangkok

The Medicine Quality Research Group has published a new Medical Product Quality Report focussing on increasing issues around substandard and falsified (SF) COVID-19 vaccines. With the implementation of the key innovations of COVID-19 vaccines, there have been growing numbers of reports of SF vaccines in the public domain. Given the vital role they will play in ending the pandemic and protecting the global population but severe issues with equitable access, SF vaccines are highly likely to be a growing problem.